BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 25983087)

  • 1. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
    Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
    Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes associated with melanoma metastasis.
    Qiu T; Wang H; Wang Y; Zhang Y; Hui Q; Tao K
    Kaohsiung J Med Sci; 2015 Nov; 31(11):553-61. PubMed ID: 26678934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
    Chen B; Sun D; Qin X; Gao XH
    Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an immunorelated protein-protein interaction network for clarifying the mechanism of burn.
    Gao Y; Nai W; Yang L; Lu Z; Shi P; Jin H; Wen H; Wang G
    Burns; 2016 Mar; 42(2):405-13. PubMed ID: 26739088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
    Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Analysis of Molecular Mechanisms in Primary and Metastatic Melanoma.
    Xu Y; Mu Y; Wang L; Zhang X
    J Comput Biol; 2020 Jan; 27(1):9-19. PubMed ID: 31424282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of differentially expressed genes between endometrial carcinosarcomas and endometrioid endometrial carcinoma by bioinformatics.
    Lin H; Zhang M; Yu H; Zhang H; Li Y; Xu J; Chen X; Chen Y
    Arch Gynecol Obstet; 2016 May; 293(5):1073-9. PubMed ID: 26374646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis.
    Xie J; Wu Z; Xu X; Liang G; Xu J
    Medicine (Baltimore); 2020 Oct; 99(43):e22974. PubMed ID: 33120861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
    Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening candidate genes associated with bladder cancer using DNA microarray.
    Xu A; Wang C; Sun S
    Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.